Recent studies have also demonstrated altered cytokine activity in schizophrenia,31–34 and enhancement of IFIT2 and IFIT3 by RP5-998N21.4 and the subsequent promotion of the immune defense response might partially counteract the defects caused by the disease, with protective or restorative effects against neurotoxicity. The gene discussed is IFIT3; the disease is schizophrenia.